Tag Archives: gprc5d targeted therapy

Advances in Multiple Myeloma Treatment: Immunotherapies and Targeted Therapies

Almost a decade ago, the FDA approved daratumumab (Darzalex), a groundbreaking monoclonal antibody for multiple.....Read more